Gushengtang Holdings Limited (FRA:F2P)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	947	1,009	1,438	1,396	1,063	-
Market Cap Growth	-29.83%	-29.83%	2.96%	31.40%	-	-
Enterprise Value	872	901	1,321	1,314	1,289	-
Last Close Price	4.02	3.85	5.66	5.66	-	-
PE Ratio	23.32	24.85	44.68	56.91	-	-
PS Ratio	2.37	2.52	4.85	6.34	5.60	-
PB Ratio	3.01	3.21	4.89	5.99	4.96	-
P/TBV Ratio	5.85	6.24	8.70	11.80	9.26	-
P/FCF Ratio	19.71	21.00	33.77	42.18	55.62	-
P/OCF Ratio	15.81	16.85	27.47	36.63	40.89	-
EV/Sales Ratio	2.46	2.25	4.46	5.96	6.79	-
EV/EBITDA Ratio	15.15	17.35	36.27	44.31	-	-
EV/EBIT Ratio	21.61	19.76	40.59	51.80	-	-
EV/FCF Ratio	18.16	18.76	31.03	39.70	67.44	-
Debt / Equity Ratio	0.21	0.21	0.16	0.20	0.22	-1.83
Debt / EBITDA Ratio	1.04	1.04	1.00	1.21	330.18	12.86
Debt / FCF Ratio	1.40	1.40	1.11	1.44	2.50	15.22
Asset Turnover	0.86	0.86	0.78	0.65	0.72	0.73
Inventory Turnover	12.71	12.71	12.59	12.35	11.13	9.49
Quick Ratio	1.85	1.85	2.13	2.01	2.12	0.20
Current Ratio	2.38	2.38	2.60	2.45	2.49	0.30
Return on Equity (ROE)	13.12%	13.12%	12.57%	11.09%	-243.63%	-
Return on Assets (ROA)	6.12%	6.12%	5.32%	4.67%	-2.89%	4.76%
Return on Capital (ROIC)	7.75%	7.75%	6.72%	5.90%	-3.91%	7.39%
Return on Capital Employed (ROCE)	11.90%	11.90%	9.60%	9.10%	-	-
Earnings Yield	4.29%	4.02%	2.24%	1.76%	-6.60%	-
FCF Yield	5.07%	4.76%	2.96%	2.37%	1.80%	-
Dividend Yield	1.14%	1.74%	-	-	-	-
Payout Ratio	9.21%	9.21%	35.59%	-	-	-
Buyback Yield / Dilution	-2.78%	-2.78%	-2.17%	-106.52%	-48.40%	-
Total Shareholder Return	-1.64%	-1.03%	-2.17%	-106.52%	-48.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.